In light of this week’s good news on the legal front of the war against ObamaCare, Medical Progress Today, a project of the Manhattan Institute, asked a collection of leading health policy experts for their opinions on whether ObamaCare can still stand if the individual mandate is removed.

An interview with ObamaCare Watch’s Project Director Jim Capretta in which he discusses the ruling by a federal judge finding ObamaCare’s individual mandate unconstitutional.

“In a stinging rebuke to the Obama administration, a federal judge Monday invalidated a key provision of the recently passed health care law, saying that it ‘exceeds the constitutional boundaries of congressional power.'”

“The healthcare reform law flunks the test of real healthcare reform. Real reform would: encourage providers to offer higher-quality care at lower costs; reduce the cost pressures that threaten to bankrupt Medicare and Medicaid; and give every American access to more options for quality insurance. To enact real healthcare reform, and help to restore fiscal balance to the nation’s budget, the next Congress should pursue substantial changes to the Patient Protection and Affordable Care Act (PPACA). We recommend the following five healthcare objectives for the 112th Congress.”

ObamaCare levies a $20 billion tax on medical device companies, which will reduce incentives for innovation and raise the cost of care. It will likely be one of the first targets for repeal.

“The health-care overhaul has taken some of the flex out of flexible spending accounts, which let workers pay medical expenses with pretax dollars. Starting in January, you’ll no longer be able to use your FSA for over-the-counter drugs and medicines unless you have a doctor’s prescription. Experts agree that the new rules will likely discourage people from tapping their FSAs for routine purchases of aspirin, vitamins, cough medicine and other drugstore essentials.”

ObamaCare is paid for partly with new taxes on health firms, especially medical device manufacturers and drug companies. These taxes will discourage medical innovation and drive up the cost of care.

“ObamaCare doesn’t reduce medical costs under even the rosiest of scenarios (that is, projections that take seriously all its creators’ assumptions). What we can be certain of is that this legislation increases the amount of money taxpayers will be forced by law to pay for health insurance to the tune of $420 billion over the next 10 years. Claims about ObamaCare’s deficit-reduction effects depend on new taxes growing even faster than new spending. Despite the persistent claims of Peter Orszag and other defenders of the president’s health care legislation, ObamaCare has nothing to do with cutting costs.”

“Voters in Oklahoma and Arizona resoundingly supported ballot initiatives to opt-out of the federal health reform law, while Colorado voters appeared headed to rejecting a similar measure.”

“It is true that the tax credits will reduce the effective premium that many households will face for health insurance coverage. However, the key question from a policy perspective is whether the benefits of the Obamacare tax credits outweigh their costs. Since the Families USA report failed to list any of the costs or concerns of the Obamacare tax credits, Heritage will fill the void.”